Live Breaking News & Updates on European Cancer Patient Advocacy

The use of immune therapies for hematological malignancies is expanding beyond chimeric antigen receptor (CAR) T-cell therapies in the traditional lymphoid disease states, but the impact on patient quality of life must remain top of mind, according to speakers at the European Hematology Association 2023 Congress. ....

Hermann Einsele , Hans Scheurer , Karolinska Institutet , Emma Morris , Stephan Mielke , Workgroup Of European Cancer Patient Advocacy Networks , University College London , European Hematology Association , Professor Emma Morris , University College , Professor Stephan Mielke , European Cancer Patient Advocacy , Patients Europe ,